UMIN-ICDS Clinical Trial
| Unique ID issued by UMIN | UMIN000061910 |
|---|---|
| Receipt number | R000070839 |
| Scientific Title | Effects of Functional Recovery Wear on Recovery After High-Load Exercise |
| Date of disclosure of the study information | 2026/06/16 |
| Last modified on | 2026/06/15 07:41:29 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Effects of Functional Recovery Wear on Recovery After High-Load Exercise
Acronym
Effects of Functional Recovery Wear on Recovery After High-Load Exercise
Scientific Title
Effects of Functional Recovery Wear on Recovery After High-Load Exercise
Scientific Title:Acronym
Effects of Functional Recovery Wear on Recovery After High-Load Exercise
Region
| Japan |
Condition
Condition
Healthy male
Classification by specialty
| Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To investigate the effects of functional wear on recovery after high-load exercise
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Time-course changes and between-trial comparisons of salivary cortisol levels up to 120 minutes post-exercise.
Key secondary outcomes
Time-course changes and between-trial comparisons of heart rate variability indices during acute recovery up to 120 minutes post-exercise.
Time-course changes and between-trial comparisons of subjective scores using the Visual Analog Scale up to 120 minutes post-exercise.
Daily physical conditions and training workload from 7 days prior to the test to the end of the study.
Base
Study type
Interventional
Study design
Basic design
Cross-over
Randomization
Randomized
Randomization unit
Individual
Blinding
Double blind -all involved are blinded
Control
Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Treatment
Type of intervention
| Device,equipment |
Interventions/Control_1
Test wear
Interventions/Control_2
Control wear
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male
Key inclusion criteria
1) Healthy Japanese males aged 18 years or older.
2) Individuals who regularly engage in high-intensity training and are judged to be capable of tolerating the exercise workload of this study based on the results of pre-test maximal oxygen uptake (VO2max) measurement or other evaluations.
3) Individuals who have provided voluntary written informed consent to participate in this study.
4) Individuals judged by the prinipal investigator or sub-investigator to have no problems participating in this study based on the results of screenings or tests.
Key exclusion criteria
1) Individuals taking medications that affect hemodynamics for the treatment of cardiovascular disease, hypertension, or other conditions.
2) Individuals undergoing medical treatment or taking medication for sleep-related disorders, such as insomnia.
3) Individuals who routinely wear blood-circulation-enhancing garments.
4) Individuals with an underweight or obese body type.
5) Individuals with a smoking habit.
6) Individuals with a daily caffeine intake of 300 mg or more.
7) Individuals with an irregular lifestyle.
8) Individuals who have engaged in night-shift work (after 22:00) within the past 3 months.
9) Individuals who have traveled to a country with a time difference of 3 hours or more within the past 3 months.
10) Individuals who experience events during the study period that could pose a significant confounding effect on the measured outcomes.
11) Individuals otherwise judged to be inappropriate for participation in the study by the principal investigator or sub-investigator.
Target sample size
30
Research contact person
Name of lead principal investigator
| 1st name | Ryosuke |
| Middle name | |
| Last name | Takahashi |
Organization
EUPHORIA Co., Ltd.
Division name
Corporate Business Division
Zip code
102-0083
Address
10th Floor, Crystal City East Building, 4-8-1 Kojimachi, Chiyoda-ku, Tokyo, Japan
TEL
03-6388-9260
ryosuke.takahashi@eu-phoria.jp
Public contact
Name of contact person
| 1st name | Yuki |
| Middle name | |
| Last name | Urushizawa |
Organization
EUPHORIA Co., Ltd.
Division name
Corporate Business Division
Zip code
102-0083
Address
10th Floor, Crystal City East Building, 4-8-1 Kojimachi, Chiyoda-ku, Tokyo, Japan
TEL
03-6388-9260
Homepage URL
yuki.urushizawa@eu-phoria.jp
Sponsor or person
Institute
EUPHORIA Co., Ltd.
Institute
Department
Personal name
Funding Source
Organization
TENTIAL Inc.
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Shiba Palace Clinic Ethics Review Committee
Address
DaiwaA Hamamatsucho Bldg. 6F, 1-9-10, Hamamatsucho, Minato-ku, Tokyo, 105-0013, Japan
Tel
03-5408-1599
shiba_palace@s-palace-clinic.com
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2026 | Year | 06 | Month | 16 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2026 | Year | 06 | Month | 11 | Day |
Date of IRB
| 2026 | Year | 06 | Month | 11 | Day |
Anticipated trial start date
| 2026 | Year | 06 | Month | 17 | Day |
Last follow-up date
| 2026 | Year | 09 | Month | 30 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2026 | Year | 06 | Month | 15 | Day |
Last modified on
| 2026 | Year | 06 | Month | 15 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000070839
